Suppr超能文献

与TBK1基因p.Tyr235Phe突变相关的早发性阿尔茨海默病病例分析

Case analysis of early-onset Alzheimer's disease associated with TBK1 p.Tyr235Phe gene mutation.

作者信息

Li Pan, Y Yuanyuan, Cai Hao, Zhang Huihong, Zhou Yuying

机构信息

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Department of Neurology, Tianjin Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Huanhu Hospital Affiliated to Nankai University, Tianjin University Huanhu Hospital, Tianjin, China.

出版信息

Front Neurol. 2022 Nov 3;13:993399. doi: 10.3389/fneur.2022.993399. eCollection 2022.

Abstract

TANK1-binding kinase 1 (TBK1) is mainly involved in the regulation of various cellular pathways through the autophagic lysosomal system, and the loss of function or hypofunction caused by TBK1 gene mutation mainly leads to frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and ALS-FTLD. Alzheimer's disease (AD) due to TBK1 gene mutation is extremely rare, and only one case has been reported in China so far. In this report, we described a patient with early-onset AD (EOAD) in whom a new probable pathogenic variant c.704A>T (p.Tyr235Phe) in the TBK1 gene was identified by a whole-genome sequencing analysis. It is suggested that FTLD gene mutation may exist in patients with clinical manifestations of AD.

摘要

TANK1结合激酶1(TBK1)主要通过自噬溶酶体系统参与多种细胞途径的调节,TBK1基因突变导致的功能丧失或功能减退主要引发额颞叶痴呆(FTLD)、肌萎缩侧索硬化症(ALS)以及ALS-FTLD。由TBK1基因突变引起的阿尔茨海默病(AD)极为罕见,迄今为止中国仅报道过一例。在本报告中,我们描述了一名早发性AD(EOAD)患者,通过全基因组测序分析在其体内鉴定出一种新的可能致病变异c.704A>T(p.Tyr235Phe)。提示具有AD临床表现的患者可能存在FTLD基因突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/082e/9671219/4321cb795985/fneur-13-993399-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验